Nonoxidative pentose phosphate pathways and their direct role in ribose synthesis in tumors: is cancer a disease of cellular glucose metabolism?

[1]  L. Boros,et al.  Dehydroepiandrosterone-sulfate inhibits pancreatic carcinoma cell proliferation in vitro and in vivo. , 1997, Surgery.

[2]  W E Fisher,et al.  Insulin promotes pancreatic cancer: evidence for endocrine influence on exocrine pancreatic tumors. , 1996, Journal of Surgical Research.

[3]  Saroj P. Mathupala,et al.  Glucose catabolism in cancer cells: regulation of the type II hexokinase promoter by glucose and cyclic AMP , 1996, FEBS letters.

[4]  F. Tabita,et al.  Expression of the cbbLcbbS and cbbM genes and distinct organization of the cbb Calvin cycle structural genes of Rhodobacter capsulatus , 1995, Archives of Microbiology.

[5]  J. Meeks,et al.  Genetic evidence of a major role for glucose-6-phosphate dehydrogenase in nitrogen fixation and dark growth of the cyanobacterium Nostoc sp. strain ATCC 29133 , 1995, Journal of bacteriology.

[6]  R L Wahl,et al.  Fluorine-18-fluorodeoxyglucose-guided breast cancer surgery with a positron-sensitive probe: validation in preclinical studies. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  Y Yonekura,et al.  In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  S. Bassilian,et al.  Isotopomer study of lipogenesis in human hepatoma cells in culture: contribution of carbon and hydrogen atoms from glucose. , 1995, Analytical biochemistry.

[9]  B. Ross,et al.  Measurement of pentose phosphate-pathway activity in a single incubation with [1,6-13C2,6,6-2H2]glucose. , 1994, The Biochemical journal.

[10]  S. Hauptmann,et al.  F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer. , 1994, Radiology.

[11]  R. Schuster,et al.  Metabolic flux determination in C6 glioma cells using carbon-13 distribution upon [1-13C]glucose incubation. , 1993, European journal of biochemistry.

[12]  Trebukhina Rv,et al.  The effect of oxythiamine on tumor growth and certain biochemical and genetic characteristics of normal and tumor cells , 1992 .

[13]  T. Slater,et al.  Increased activity of 6-phosphogluconate dehydrogenase and glucose-6-phosphate dehydrogenase in purified cell suspensions and single cells from the uterine cervix in cervical intraepithelial neoplasia. , 1992, British Journal of Cancer.

[14]  L G Strauss,et al.  The applications of PET in clinical oncology. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  T. Krick,et al.  Hexose monophosphate shunt measurement in cultured cells with [1-13C]glucose: correction for endogenous carbon sources using [6-13C] glucose. , 1990, Analytical biochemistry.

[16]  P. Cocco,et al.  Glucose-6-phosphate dehydrogenase deficiency and cancer in a Sardinian male population: a case-control study. , 1989, Carcinogenesis.

[17]  S. Nagataki,et al.  Glucose stimulation of protooncogene expression and deoxyribonucleic acid synthesis in rat islet cell line. , 1988, Endocrinology.

[18]  O. Warburg.  [Origin of cancer cells]. , 1956, Oncologia.

[19]  Otto Warburn,et al.  THE METABOLISM OF TUMORS , 1931 .

[20]  M. Benito,et al.  Glucose-6-phosphate dehydrogenase gene expression in fetal hepatocyte primary cultures under nonproliferative and proliferative conditions. , 1994, Experimental cell research.

[21]  E. Eigenbrodt,et al.  Double role for pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells. , 1992, Critical reviews in oncogenesis.

[22]  Ostrovskiĭ IuM,et al.  [Comparative evaluation of the action of oxythiamine and its derivatives on animals with Erhlich's ascitic cancer]. , 1986 .

[23]  J. Dickerson,et al.  The thiamin status of early cancer patients with particular reference to those with breast and bronchial carcinomas. , 1976, Oncology.